Lyra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	22.06	40.58	22.35	32.55	45.75	74.59
Short-Term Investments	-	-	80.4	65.34	-	-
Cash & Short-Term Investments	22.06	40.58	102.75	97.89	45.75	74.59
Cash Growth	-57.28%	-60.51%	4.96%	113.99%	-38.67%	660.53%
Other Current Assets	0.96	2.45	2.07	2.94	2.17	1.32
Total Current Assets	23.02	43.03	104.82	100.83	47.92	75.92
Net Property, Plant & Equipment	18.7	21.33	35.28	4.47	5.86	4.47
Other Long-Term Assets	1.99	1.99	2.5	4.67	1.09	0.45
Total Assets	43.71	66.35	142.6	109.97	54.87	80.83
Accounts Payable	0.63	1.18	3.13	2.62	3.13	0.92
Accrued Expenses	1.1	2.59	9.37	9.03	4.26	2.98
Current Portion of Leases	4.68	4.12	5.43	1.55	1.07	0.99
Unearned Revenue	0.01	0.4	1.66	1.28	9.79	-
Other Current Liabilities	3.06	4.35	-	-	-	-
Total Current Liabilities	9.48	12.63	19.6	14.47	18.25	4.88
Long-Term Leases	26.7	30.26	21.45	0.67	0.38	1.45
Other Long-Term Liabilities	11.86	11.86	12.14	14.08	1.93	-
Total Long-Term Liabilities	38.56	42.12	33.58	14.74	2.31	1.45
Total Liabilities	48.04	54.75	53.18	29.21	20.55	6.34
Common Stock	0	0	0.06	0.03	0.01	0.01
Additional Paid-in Capital	422.43	416.38	400.69	329.39	227.7	224.36
Accumulated Other Comprehensive Income	-	-	0.03	0.01	-	-
Retained Earnings	-426.76	-404.79	-311.36	-248.68	-193.4	-149.88
Total Common Shareholders' Equity	-4.33	11.59	89.42	80.75	34.32	74.49
Shareholders' Equity	-4.33	11.59	89.42	80.75	34.32	74.49
Total Liabilities & Equity	43.71	66.35	142.6	109.97	54.87	80.83
Total Debt	31.38	34.38	26.88	2.22	1.45	2.44
Net Cash (Debt)	-9.32	6.2	75.87	95.68	44.29	72.15
Net Cash Growth	-	-91.83%	-20.70%	116.01%	-38.61%	1013.14%
Net Cash Per Share	-6.50	4.76	76.17	158.22	170.54	419.98
Book Value	-4.33	11.59	89.42	80.75	34.32	74.49
Book Value Per Share	-3.02	8.90	89.77	133.54	132.13	433.59
Tangible Book Value	-4.33	11.59	89.42	80.75	34.32	74.49
Tangible Book Value Per Share	-3.02	8.90	89.77	133.54	132.13	433.59

Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q